Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome. Eva Maria Wendel , Helen Sophie Thonke , Annikki Bertolini , Matthias Baumann , Astrid Blaschek , Andreas Merkenschlager , Michael Karenfort , Barbara Kornek , Christian Lechner , Daniela Pohl , Martin Pritsch , Kathrin Schanda , Mareike Schimmel , Charlotte Thiels , Stephan Waltz , Gert Wiegand , Banu Anlar , Nina Barisic , Christian Blank , Markus Breu , Philip Broser , Adela Della Marina , Katharina Diepold , Matthias Eckenweiler , Astrid Eisenkölbl , Michael Freilinger , Ursula Gruber-Sedlmayr , Annette Hackenberg , Tobias Iff , Ellen Knierim , Johannes Koch , Georg Kutschke , Steffen Leiz , Grischa Lischetzki , Margherita Nosadini , Alexander Pschibul , Edith Reiter-Fink , Doris Rohrbach , Michela Salandin , Stefano Sartori , Jan-Ulrich Schlump , Johannes Stoffels , Jurgis Strautmanis , Daniel Tibussek , Victoria Tüngler , Norbert Utzig , Markus Reindl , Kevin Rostásy Abstracts of the 46th Annual Meeting of the Society for NeuropediatricsNeuropediatrics（2022）
摘要
In this study, patients with declining MOG-IgG titers, particularly those with seroconversion to MOG-IgG-negative, are shown to have a significantly reduced relapse risk.
更多 查看译文
关键词
mog antibodies, syndrome
AI 理解论文
溯源树
样例
